Nearly half of health system revenue cycle operations are stuck in a 50/50 split between reactive manual processes and proactive AI automation. That's the finding from an HFMA executive roundtable in September 2026, where seven revenue cycle leaders from organizations including Yale New Haven Health, LifeBridge Health, and Hackensack Meridian Health described the current state of AI adoption in healthcare billing. The consensus was stark: while payers deploy AI to deny claims at rates 16 times higher than typical manual review, most providers are still chasing denials after the fact — burning staff hours on work that should never have been necessary.
The arms race is real. But the providers winning it aren't fighting harder on the back end. They're moving the fight upstream.
The Payer AI Arms Race: Why Reactive Denial Management Is a Losing Strategy
The US Senate Permanent Subcommittee on Investigations reported in October 2024 that major payers are using AI systems to deny claims at rates 16 times higher than traditional manual review. That single data point reframes the entire denial management conversation. Manual appeal processes that already struggled to keep pace with human reviewers now face AI-powered denial engines that operate at machine speed and scale.
But the denial rate isn't the only problem. Payers are also masking denials as contractual adjustments — reducing payments through code reclassifications and bundling edits that never appear in denial work queues. If a claim doesn't register as denied, it never gets appealed. The revenue simply disappears.
The financial pressure is compounding. Write-off thresholds at health systems have dropped from $750 to $50 in five years, according to HFMA roundtable panelists. That means payers are taking smaller bites more often — death by a thousand cuts that manual processes can't track at scale.
Organizations that continue to rely on reactive denial management — waiting for a denial to arrive, then scrambling to appeal — are playing a game they structurally cannot win. The payer has more AI, more automation, and more time. The only viable response is to prevent the denial from happening in the first place.
The Upstream Shift: Where AI Prevention Actually Works
The HFMA roundtable wasn't theoretical. Panelists shared specific upstream interventions that are producing measurable results right now. The common thread: moving AI to the front of the revenue cycle, where it can catch errors, fill gaps, and enforce compliance before a claim ever reaches a payer.
Automated Notice of Admissions on Evenings and Weekends
Authorization-related denials represent one of the largest denial categories for hospitals. A significant portion stem from a simple timing problem: admissions happen around the clock, but authorization staff work business hours. AI-automated NOA (notice of admission) submissions on evenings, nights, and weekends close that gap entirely. Panelists reported a significant downshift in authorization-related denials after deploying automated NOA workflows that operate 24/7 without human intervention.
Hard Stops in EHR Systems at Scheduling
One of the most effective upstream interventions is deceptively simple: replacing warning stops with hard stops in Epic and other EHR systems for required data capture at scheduling. Warning stops get clicked past. Hard stops don't. When the required insurance information, referral number, or authorization code must be entered before a schedule slot is confirmed, the downstream data quality improves dramatically. As Danielle Reese, VP of Patient Access at Hackensack Meridian Health, described it — the data has to be right before the patient ever walks in the door.
Ambient Listening for Clinical Documentation Capture
Clinical documentation drives claim accuracy, and clinical documentation is where many denials originate. Layered technology that uses ambient listening to capture clinical encounters and then predicts claim outcomes upstream is emerging as a powerful denial prevention tool. The AI listens during the encounter, identifies documentation gaps that would trigger a medical necessity denial or coding downcode, and flags them in real time — before the claim is coded, before it's scrubbed, before it's submitted. By the time the claim leaves the building, the documentation supports it.
AI-Translated Authorization Forms
Complex prior authorization paperwork is a time sink that directly contributes to delayed claims and missed filing windows. One health system reported that AI translation of radiopharmaceutical authorization forms cut the process from 40 minutes to seconds. That's not incremental improvement. That's a category change in how authorization work gets done — and it frees staff to handle the complex cases that actually need human judgment.
AI Appeal Letters: 1 Hour to 30 Seconds
When denials do occur, AI dramatically compresses the response time. Staff load payer policies and the draft denial into the system, and receive a rewritten second-level appeal letter in 30 seconds — work that previously took an hour of manual research and writing. This isn't upstream prevention, but it's the force multiplier that makes the entire model work: even the reactive work becomes fast enough that staff can redirect the saved time into prevention.
DRG-Specific Denial Analysis Driving Policy Changes
Jonathan Davis, Executive Director of Revenue Cycle at Yale New Haven Health, shared a powerful example: DRG-specific denial analysis revealed that the organization was losing 90% of appeals on specific inpatient cases. Rather than continuing to fight losing appeals, the data drove an upstream policy change — reclassifying those procedures to outpatient classification, where the denial rate dropped significantly. That's the real value of AI in denial management: not just fighting faster, but identifying which fights shouldn't be fought at all.
Augmented Intelligence: Why the Framing Matters
The HFMA panelists were deliberate about language. The term they used wasn't "artificial intelligence" — it was "augmented intelligence." The distinction matters for adoption, organizational trust, and outcomes.
Augmented intelligence means AI that complements employees and allows them to focus on higher-value tasks. AI handles the volume — eligibility checks, claim scrubbing, NOA submissions, appeal drafts. Humans handle the complexity — payer negotiations, exception cases, policy interpretation. This isn't a philosophical distinction. It's a practical framework that determines whether staff resist or adopt the technology.
One health system launched AI in HR first — where a bot eliminated 75% of organizational calls — before introducing it to revenue cycle. Staff built comfort by using AI for non-clinical tasks like rewording emails before progressing to appeal letters and clinical documentation.
The trust-building sequence is intentional and it works. Exception-based workflows — where AI handles the standard cases and humans handle the outliers — reinforce the message that AI complements rather than replaces. The revenue cycle leaders at the roundtable were clear: the organizations seeing the best results are the ones that invested in trust-building alongside technology deployment.
The 50/50 Split: Where Most Organizations Are Today
The most striking finding from the HFMA roundtable was the candid admission that nearly half of the room described their organizations as evenly split between reactive manual processes and proactive AI automation. Not 80/20. Not 70/30. A 50/50 split — meaning that for every dollar of denial work that AI handles proactively, another dollar is still being chased manually after the fact.
| Revenue Cycle Activity | Reactive (Manual) | Proactive (AI-Enabled) |
|---|---|---|
| Denial management | Post-denial appeal queues, manual letter writing | AI appeal drafts in 30 seconds, DRG-specific prevention |
| Prior authorization | Manual fax/phone/portal submissions | AI-automated NOAs, form translation in seconds |
| Clinical documentation | Post-encounter CDI review | Ambient listening with real-time gap alerts |
| Patient access | Warning stops, incomplete data at scheduling | Hard stops, centralized financial clearance with AI QA dashboards |
| Payment integrity | Manual ERA/EOB review for obvious denials only | AI detection of masked denials in contractual adjustments |
The gap represents real money. Every claim that could have been prevented from denial but wasn't — because the intervention happened reactively instead of proactively — costs the organization in staff time, appeal resources, delayed revenue, and write-offs. At scale, the difference between a 50/50 split and an 80/20 proactive ratio can mean millions in recovered revenue annually.
Practical Recommendations: How to Shift Your Ratio
The HFMA panelists converged on several principles for organizations looking to accelerate their shift from reactive to proactive:
Don't boil the ocean. Be intentional about which use case to apply AI to first. Pick the highest-volume, most-preventable denial category and deploy AI there. Prove the ROI. Then expand.
Quantify impact through dollars, not "efficiency." Revenue cycle leaders said the most effective way to build organizational support for AI is measuring impact in dollars recovered, FTE capacity created, or growth enabled — not abstract efficiency metrics. If the AI prevented $400K in denials last quarter, that's a number the CFO understands.
Keep AI contracts short. Joseph Koons, SVP and Chief Revenue Officer at LifeBridge Health, recommended short-term AI contracts because the technology is changing too rapidly for long commitments. Evaluate results quarterly. If the vendor isn't delivering, switch. The market is moving fast enough that better options will emerge.
Find solutions that bring value today. Multiple panelists stressed that the perfect AI solution with a 12-month implementation timeline is worse than an imperfect solution that delivers ROI in 30 days. The revenue losses are happening now. The response needs to be equally immediate.
Build centralized financial clearance teams. Organizations with the strongest upstream prevention have centralized financial clearance teams supported by AI quality assurance dashboards that track performance down to the individual user level. This creates accountability, identifies training gaps, and ensures the AI and human components of the workflow reinforce each other.
Where BAM AI Fits: Augmented Intelligence for Medical Practices
BAM AI's approach to denial management mirrors what the HFMA roundtable described as the ideal model: augmented intelligence that moves interventions upstream while keeping humans in control of complex decisions.
BAM AI agents operate across the full upstream prevention chain — automated eligibility and insurance verification at scheduling, prior authorization automation with real-time status tracking, clinical documentation support that flags coding risks before submission, and AI-powered appeal generation when denials do occur. The system is designed for medical practices and hospitals that need to shift their reactive-proactive ratio without replacing their existing teams.
The augmented intelligence framework means your staff stays in the loop on exceptions, payer disputes, and policy decisions. AI handles the volume. Your team handles the judgment calls. The result is a revenue cycle that prevents more, appeals faster, and recovers revenue that would otherwise disappear into payer contractual adjustments.